Functional Diagnostic Accuracy of Quantitative Flow Ratio in Tandem Lesions and Virtual Stenting
NCT ID: NCT03405506
Last Updated: 2025-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
308 participants
OBSERVATIONAL
2017-06-13
2017-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to evaluate the diagnostic accuracy of QFR in in tandem lesions with fractional flow reserve (FFR) as the reference standard. The secondary purpose is to evaluate the diagnostic accuracy of QFR-based virtual stent technique in predicting the FFR values after revascularizing the culprit lesion.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multicenter Registry for Angiography-Derived Quantitative Flow Ratio
NCT03791788
Angio-based Fractional Flow Reserve to Predict Adverse Events After Stent Implantation
NCT02811796
Computed Tomography-derived Fractional Flow Reserve vs. Angiographic Quantitative Flow Ratio in Management of Patients With Coronary Artery Disease
NCT07308496
Diagnostic Accuracy of Quantitative Flow Ratio
NCT06305572
µQFR for Branch Stenosis After Single Stent in Bifurcation Lesions
NCT07116083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The FAVOR Pilot Study and FAVOR II China Study showed promising results for diagnostic accuracy in consecutive patients. However, the diagnostic accuracy of QFR in specific tandem lesions needs further investigation. Furthermore, using the virtual stent technology to accurately assess the culprit lesion and choose the optimal treatment is significant in precisely guiding PCI surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quantitative Flow Ratio (QFR)
FFR measured by pressure wire, QFR computed by coronary angiographic images
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age \> 18 years;
3. Able to provide signed informed consent.
1. At least two localized lesions on the same coronary artery;
2. More than 50% diameter stenosis (DS) estimated by QCA on each lesion;
3. At least 10 mm relatively normal lumen (at most 20% DS) between two lesions;
4. Reference vessel size \> 2 mm in stenotic segment by visual estimate.
Exclusion Criteria
2. Myocardial infarction within 72 hours;
3. Severe heart failure (NYHA≥III);
4. S-creatinine\>150µmol/L or GFR\<45 ml/kg/1.73m2;
5. Allergy to contrast agent or adenosine;
6. Factors that might substantially impact the angiographic image quality, e.g, frequent atrial premature beat or atrial fibrillation;
7. Serious complications:
1. Evidence of cardiac rupture;
2. History of bleeding (intracranial hemorrhage, gastrointestinal bleeding, etc.);
3. Acute or chronic blood system diseases, including hemoglobin \< 10 g / L, or platelet count \< 50 × 109 / L;
4. Accompanied by other diseases might inducing life expectancy shorter than several months;
5. History of severe renal insufficiency and hypohepatia (liver failure, cirrhosis, portal hypertension and active hepatitis)
6. Aneurysm, arterial / venous malformation, aortic dissection;
8. Cardiogenic shock or circulation capacity failure;
9. Two-degree and more severe atrioventricular block, with no permanent pacemaker implanted;
10. Pregnancy or lactation;
11. The investigators believe that the treatment regimen may be detrimental to the patient or the enrollment of this subject may affect the specific assessment of the trial;
1. The interrogated stenosis is caused by myocardial bridge;
2. Ostial lesions less than 3 mm to the aorta;
3. Side branches of the bifurcation lesions with Median Classification of 111 or 101;
4. Severe overlap or shorten of stenosis segment;
5. Severe tortuosity of target vessel;
6. Poor angiographic image quality precluding contour detection.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Chest Hospital
OTHER
Pulse Medical Imaging Technology (Shanghai) Co., Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Huadong Hospital affiliated to Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tu S, Westra J, Yang J, von Birgelen C, Ferrara A, Pellicano M, Nef H, Tebaldi M, Murasato Y, Lansky A, Barbato E, van der Heijden LC, Reiber JHC, Holm NR, Wijns W; FAVOR Pilot Trial Study Group. Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary Angiography: The International Multicenter FAVOR Pilot Study. JACC Cardiovasc Interv. 2016 Oct 10;9(19):2024-2035. doi: 10.1016/j.jcin.2016.07.013.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CARDIAC201701
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.